↓ Skip to main content

TCR diversity – a universal cancer immunotherapy biomarker?

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
TCR diversity – a universal cancer immunotherapy biomarker?
Published in
Journal for Immunotherapy of Cancer, November 2016
DOI 10.1186/s40425-016-0175-4
Pubmed ID
Authors

Douglas G. McNeel

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 27%
Student > Bachelor 11 14%
Student > Master 9 12%
Other 7 9%
Student > Ph. D. Student 6 8%
Other 12 15%
Unknown 12 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 22%
Agricultural and Biological Sciences 16 21%
Medicine and Dentistry 15 19%
Immunology and Microbiology 7 9%
Engineering 3 4%
Other 7 9%
Unknown 13 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2022.
All research outputs
#6,996,768
of 22,925,760 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,616
of 2,942 outputs
Outputs of similar age
#103,447
of 306,597 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#21
of 32 outputs
Altmetric has tracked 22,925,760 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,942 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.